This report on epilepsy represents selections from the larger market research study on neurotherapeutic drugs published by Kalorama Information in August 2002. The full study looked at the entire range of non-psychiatric neurological diseases and their treatments in the top seven world health markets. Here we present those parts of that study that are germane to epilepsy.
In addition to the selections relevant to epilepsy, we have also included the following from the full study in this report:
The complete Executive Summary from the full study;
Discussion of promising cutting-edge technologies and treatments with potentially broad application not limited to epilepsy;
Top-level market numbers on the total worldwide market for neurotherapeutic drugs;
The Conclusions and Strategic Implications from the full study;